Received Jun 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Patient stated having blood pressure.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of blood pressure abnormal in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced blood pressure abnormal (Verbatim: Patient stated having blood pressure.). The outcome of the blood pressure abnormal was not reported. It was unknown if the reporter considered the blood pressure abnormal to be related to Shingrix. It was unknown if the company considered the blood pressure abnormal to be related to Shingrix. Additional Information: GSK Receipt Date: 03-JUN-2025 The healthcare professional (HCP) stated that he/she knew that patient (over 50 years) had blood pressure, but the reporter was unaware what she was circling for (referring to Pharmacy Patients questionnaire). The patient did not have the data about high or low blood pressure. The reporter reported that the patient marked Yes on Pharmacy's questionnaire field long term diseases without specifications. Patient stated having blood pressure.